Does metabolic syndrome increase the risk of postoperative complications in patients undergoing colorectal cancer surgery?
Diseases of the Colon and Rectum Jun 17, 2019
Shariq OA, et al. - Via this retrospective cohort study of 91,566 patients who underwent elective colectomy for colorectal cancer, researchers investigated how metabolic syndrome influnce short-term postoperative outcomes in these patients. Among these, 7603 (8.3%) had metabolic syndrome. Outcomes revealed an increased risk of 30-day postoperative renal complications, wound complications, and unplanned hospital readmissions among patients with metabolic syndrome undergoing elective surgery for colorectal cancer. Preoperative implementation of a multidisciplinary approach involving lifestyle modifications and pharmacologic interventions is recommended to improve the components of metabolic syndrome in these patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries